34 results:
31. Clinical Efficacy  
Clinical efficacy and patient benefits Several clinical pilot trials have been performed using Cerebrolysin in traumatic brain injury. Cerebrolysin was administered as an adjunctive…  
32. Disease  
Disease Traumatic brain injury (TBI) affects approx. 15 million1 individuals annually worldwide and is one of the leading causes of death. It is associated with high rates of hospitalization,…  
33. Disclaimer  
Disclaimer EVER Pharma undertakes all appropriate effort to make correct and complete information available on this website, but assumes no responsibility, guarantees or liability whatsoever that…  
34. Imprint  
Imprint The www.cerebrolysin.com site is offered to you by: EVER Neuro Pharma GmbH Oberburgau 3 4866 Unterach, Austria Phone: +43 7665 20555 0 Fax:+43 7665 20555 910 …  

Search results 31 until 34 of 34